Showing 12 out of 215 results
Herbert Smith Freehills advises sole sponsor and overall coordinators on Cutia Therapeutics' Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人和整体协调人律师为科笛集团香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on Cutia Therapeutics (02487.HK)'s …
Herbert Smith Freehills advises on Admiral Acquisition's IPO and London Stock Exchange standard listing
Herbert Smith Freehills has advised Jefferies and UBS as joint global co-ordinators and joint bookrunners on the English/US law aspects of the US$550 …
Corporate Debt and Treasury Report 2023
Corporate treasurers build resilience, agility into debt strategies amidst challenging times
Despite the majority of businesses reporting a neutral to negative business outlook corporate treasury has remained resilient in these challenging …
Kewei promotes capital markets international partner in China joint operation with Herbert Smith Freehills 科伟史密夫斐尔联营办公室晋升资本市场业务资深国际顾问
Kewei Law Firm has promoted Agatha Shen as an international partner in Shanghai, further strengthening China capital markets expertise in the firm's …
Herbert Smith Freehills advises joint sponsors on MedSci Healthcare's Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为梅斯健康香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie …
Herbert Smith Freehills advises Amarenco on its €300 million capital raising to support its growth as a solar IPP and storage energy player
International leading law firm Herbert Smith Freehills has advised Amarenco, a Franco-Irish company specialising in photovoltaic energy, on a new round …
Changing seasons: Australian IPO Review 2022
Our annual analysis of Australia’s capital markets returns, dissecting the pivot back to basics in 2022 and outlook for 2023.Consistent with global IPO …
Australian IPO Review 2022: Key US securities developments
ESG takes centre stage The increased focus on environmental, social and governance (ESG) initiatives ushered in by the changing of the US …
Australian IPO Review 2022: Regulatory developments
In 2022, ASIC has continued to be focused on forecasts, greenwashing and product design and distribution obligations. ASX released a public …
Australian IPO Review 2022: Key themes
SPB227611-Icon 1_2022 in review-DO.png 2022 in review After a record-breaking 2021, the Australian IPO market slowed …
Australian IPO Review 2022: Readying yourself for a change of season
Following a slower year for IPOs in 2022, potential IPO candidates may be sitting on the sidelines waiting for a change of season and more buoyant …
Showing 12 out of 215 results
View more